Literature DB >> 32979492

Gene networks determine predisposition to AMD.

Kaushal Sharma1, Neel Kamal Sharma2, Ramandeep Singh3, Suresh Kumar Sharma4, Akshay Anand5.   

Abstract

PURPOSE: AMD genetic studies have revealed various genetic loci as causal to AMD pathology. We have described the genetic complexity of Indian AMD by describing the interaction of genotypes and subsequent changes in protein expression under the influence of environmental factors. This can be utilized to enhance the diagnostic and therapeutic efficacy in AMD patients.
DESIGN: Genotype association was studied in 464 participants (AMD =277 & controls = 187) for eight genetic variants and their corresponding protein expression
METHODS: SNP analysis and protein expression analysis was carried out in AMD and controls in tandem with longitudinal assessment of protein levels during the course of AMD pathology. ANCOVA and contrast analysis were used to examine the genotypic interactions and corresponding alterations in protein levels. In order to identify the important genetic variants Logistic Regression (LR) modeling was carried out and to authenticate the model Area under the Receiver Operating Characteristic curve (AUROC) were also computed.
RESULTS: We have found genetic variants of rs5749482 (TIMP-3), rs11200638 (HTRA1), rs769449 (APOE) and rs6795735 (ADAMTS9) to be associated with AMD, concomitant with significant alterations of studied proteins levels. Analysis also revealed that the genetic interaction between APOE-HTRA1 genotypes and changes in LIPC levels (>6 pg/ug) by one unit change in SNP, play a crucial role in AMD. LR model suggested that the seven factors (including both genetic and environmental) can be utilized to predict the AMD cases with 88% efficacy and 95.6% AUROC.
CONCLUSION: Results suggest that diagnostic and therapeutic strategy for Indian AMD must include estimation of genetic interaction and concomitant changes in expression levels of proteins under influence of environmental factors.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age related macular degeneration; Genotype interaction; HTRA1; LIPC; Logistic regression; Personalized medicine; TIMP-3

Mesh:

Substances:

Year:  2020        PMID: 32979492     DOI: 10.1016/j.ygeno.2020.09.044

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

1.  Modulated anti-VEGF therapy under the influence of lipid metabolizing proteins in Age related macular degeneration: a pilot study.

Authors:  Kaushal Sharma; Priya Battu; Ramandeep Singh; Suresh Kumar Sharma; Akshay Anand
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

2.  Genotyping of Clinical Parameters in Age-Related Macular Degeneration.

Authors:  Priya Battu; Kaushal Sharma; Rajarathna Thangavel; Ramandeep Singh; Suresh Sharma; Vinod Srivastava; Akshay Anand
Journal:  Clin Ophthalmol       Date:  2022-02-25

Review 3.  Therapeutic Approaches for Age-Related Macular Degeneration.

Authors:  Ruth M Galindo-Camacho; Cristina Blanco-Llamero; Raquel da Ana; Mayra A Fuertes; Francisco J Señoráns; Amélia M Silva; María L García; Eliana B Souto
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.